Multiple study locations (see Central Contact); CV Therapeutics, Inc. — Palo Alto, California

Multiple study locations (see Central Contact); CV Therapeutics, Inc. is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Multiple study locations (see Central Contact); CV Therapeutics, Inc. has participated in 2 clinical trials.

Therapeutic areas: Coronary Artery Disease.

Sponsors: Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Multiple study locations (see Central Contact); CV Therapeutics, Inc.?

Multiple study locations (see Central Contact); CV Therapeutics, Inc. has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Multiple study locations (see Central Contact); CV Therapeutics, Inc. conducted?

Multiple study locations (see Central Contact); CV Therapeutics, Inc. has 2 clinical trials on record. Their work covers Coronary Artery Disease.

Is Multiple study locations (see Central Contact); CV Therapeutics, Inc. accredited by Crixeo Clinical Trials?

Multiple study locations (see Central Contact); CV Therapeutics, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Multiple study locations (see Central Contact); CV Therapeutics, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.